Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND)

Key facts

Where
Toronto, CanadaSee the site

Where in Canada

  • Sunnybrook Health Sciences CentreToronto, CanadaContact: Mehreen SiddiquiTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Sunnybrook Health Sciences Centre
Trial code
NCT05079464
Record updated
13 April 2026
Original description
People with vascular conditions are at risk of having memory problems, and these memory problems increase the risk for further cognitive decline. Brain stimulation has been used to improve mood and memory. Transcranial direct current stimulation (tDCS) is believed to work best on brain cells that are active or "primed" before stimulation. The purpose of this study is to compare the effects of exercise and tDCS on memory performance in patients who have completed cardiac rehabilitation and are at risk of cognitive decline.Read full original descriptionShow less

Exercise as a Primer for Excitatory Stimulation Study in Vascular Cognitive Impairment No Dementia (EXPRESS-V)

People with vascular conditions are at risk of having memory problems, and these memory problems increase the risk for further cognitive decline. Brain stimulation has been used to improve mood and memory. Transcranial direct current stimulation (tDCS) is believed to work best on brain cells that are active or "primed" before stimulation. The purpose of this study is to compare the effects of exercise and tDCS on memory performance in patients who have completed cardiac rehabilitation and are at risk of cognitive decline.

Inclusion: ≥50 years of age; females must be post-menopausal; Presence of cerebrovascular and/or cardiovascular risk factors or coronary artery disease; Montreal Cognitive Assessment (MoCA) <27; Sufficiently proficient in English; Must be able to exercise at a moderate intensity level; Presence of modest deficits (1 standard deviation below population norm) in one of the following domains: executive function, verbal memory, working memory, or visuospatial memory.

Exclusion: Metal implants that would preclude safe use of tDCS or neuroimaging; History of stroke; Significant neurological or psychiatric conditions (current major depressive disorder, bipolar disorder, schizophrenia); MoCA <18 and/or clinical diagnosis of dementia; Change in psychotropics within the last 4 weeks; Current benzodiazepine use due; Any medical contraindications to exercise.

ClinicalTrials.gov NCT05079464